UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Annals of oncology, 2004-01, Vol.15 (1), p.129-133

2004

Volltextzugriff (PDF)

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Annals of oncology, 2011-06, Vol.22 (6), p.1382-1391

2011

Volltextzugriff (PDF)

Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Journal of cellular and molecular medicine, 2023-07, Vol.27 (14), p.1928-1946

2023

Volltextzugriff (PDF)

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

JAAD Case Reports, 2024-06, Vol.48, p.18-22

2024

Volltextzugriff (PDF)

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Cancer, 2010-11, Vol.116 (21), p.5001-5011

2010

Volltextzugriff (PDF)

Recurrent mantle cell lymphoma in the uterine cervix: a case report

Journal of medical case reports, 2020-09, Vol.14 (1), p.138-138, Article 138

2020

Volltextzugriff (PDF)

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non‐hodgkin lymphoma

Cancer, 2002-08, Vol.95 (3), p.576-580

2002

Volltextzugriff (PDF)

EXABS-140-LYM High Grade B-Cell Lymphoma: Pathologic Classification and Treatment Recommendations

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S54-S56

2023

Volltextzugriff (PDF)

ALK-positive large B-cell lymphomas: A clinicopathologic study

Indian journal of pathology & microbiology, 2022-04, Vol.65 (2), p.381-386

2022

Volltextzugriff (PDF)

CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients

Molecular cancer, 2024-09, Vol.23 (1), p.210-9, Article 210

2024

Volltextzugriff (PDF)

The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma

Future oncology (London, England), 2023-04, Vol.19 (11), p.737-738

2023

Volltextzugriff (PDF)

Clinical pretreatment risk factors and Ga‐67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non‐Hodgkin lymphoma

Cancer, 2002-02, Vol.94 (4), p.873-878

2002

Volltextzugriff (PDF)

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-hodgkin's lymphoma: A comparison of doxorubicin and pirarubicin: A randomized phase II study

Journal of cancer research and clinical oncology, 2004-02, Vol.130 (2), p.107-113

2004

Volltextzugriff (PDF)

The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non‐Hodgkin's B‐Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The oncologist (Dayton, Ohio), 2013-05, Vol.18 (5), p.625-633

2013

Volltextzugriff (PDF)

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

Annals of oncology, 2007-06, Vol.18 (6), p.1085-1089

2007

Volltextzugriff (PDF)

Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-hodgkin lymphomas

The American journal of surgical pathology, 2012-02, Vol.36 (2), p.296-304

2012

Volltextzugriff (PDF)

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients

Cancers, 2022-03, Vol.14 (6), p.1569

2022

Volltextzugriff (PDF)

Outpatient reinduction therapy with gemcitabine, dexamethasone, Cisplatin (GDP) for patients with relapsed and refractory lymphoma

Gan to kagaku ryoho, 2015-01, Vol.42 (1), p.51

2015

Volltextzugriff (PDF)

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

OncoTargets and therapy, 2014-01, Vol.7 (default), p.865-872

2014

Volltextzugriff (PDF)

Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP

European journal of haematology, 2002-03, Vol.68 (3), p.135-143

2002

Volltextzugriff (PDF)

ABCL-719 Statewide Burden and Trend of Burkitt Lymphoma in the United States From 1990-2021: A Benchmarking Systematic Analysis for the Global Burden of Disease Study 2021

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S491-S492

2024

Volltextzugriff (PDF)

TCL-246 Peripheral T-Cell Lymphoma (PTCL) and treatment out-come Single centre retrospective study

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S522-S522

2024

Volltextzugriff (PDF)

Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma—Polish Lymphoma Research Group real-life analysis

Pharmacological reports, 2019-06, Vol.71 (3), p.473-477

2019

Volltextzugriff (PDF)

Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma

American journal of clinical oncology, 2002-12, Vol.25 (6), p.570-572

2002

Volltextzugriff (PDF)

Prognostic factors in patients with aggressive non-Hodgkin's lymphoma without complete response to first-line therapy

Advances in therapy, 2006-07, Vol.23 (4), p.534-542

2006

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(138)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(102)
Science & Technology
(99)
Life Sciences & Biomedicine
(98)
Male
(77)
Female
(75)
Oncology
(74)
Middle Aged
(64)
Adult
(58)
Lymphoma, Non-Hodgkin - Drug Therapy
(56)
Aged
(55)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(49)
Biological And Medical Sciences
(42)
Medical Sciences
(42)
Aggressive Lymphoma
(38)
Treatment Outcome
(36)
Chemotherapy
(35)
Adolescent
(34)
Lymphoma, Non-Hodgkin - Pathology
(34)
Cyclophosphamide - Administration & Dosage
(33)
Prognosis
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Recurrent mantle cell lymphoma in the uterine cervix: a case report

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non‐hodgkin lymphoma

EXABS-140-LYM High Grade B-Cell Lymphoma: Pathologic Classification and Treatment Recommendations

ALK-positive large B-cell lymphomas: A clinicopathologic study

CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients

The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma

Clinical pretreatment risk factors and Ga‐67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non‐Hodgkin lymphoma

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-hodgkin's lymphoma: A comparison of doxorubicin and pirarubicin: A randomized phase II study

The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non‐Hodgkin's B‐Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-hodgkin lymphomas

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients

Outpatient reinduction therapy with gemcitabine, dexamethasone, Cisplatin (GDP) for patients with relapsed and refractory lymphoma

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP

ABCL-719 Statewide Burden and Trend of Burkitt Lymphoma in the United States From 1990-2021: A Benchmarking Systematic Analysis for the Global Burden of Disease Study 2021

TCL-246 Peripheral T-Cell Lymphoma (PTCL) and treatment out-come Single centre retrospective study

Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma—Polish Lymphoma Research Group real-life analysis

Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma

Prognostic factors in patients with aggressive non-Hodgkin's lymphoma without complete response to first-line therapy

Aktive Filter

Suchergebnisse filtern